Glanzmann thrombasthenia successfully operated for nasal deformation with recombinant factor VIIA [3]

Indian Pediatrics

Volumn 43, Issue 12, 2006, Pages 1094-

  Bay, Ali ^a   Öner, Ahmet Faik ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLOOD CELL COUNT; CASE REPORT; CHILD HOSPITALIZATION; DYSPNEA; EPISTAXIS; GINGIVA BLEEDING; GLANZMANN DISEASE; HOSPITAL DISCHARGE; HUMAN; LETTER; MALE; NOSE MALFORMATION; SCHOOL CHILD; THROMBOCYTE TRANSFUSION; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION;

CHILD; COMORBIDITY; DYSPNEA; FACTOR VII; FOREIGN BODIES; HUMANS; MALE; NASAL SEPTUM; RECOMBINANT PROTEINS; RESPIRATORY TRACT INFECTIONS; THROMBASTHENIA;

EID: 33845914573     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Hoffman M, Monroe DM III. A cell-based model of hemostasis. Thromb Haemost 2001; 85: 958-965.
2. Lisman T, Moschatsis S, Adelmeijer J, Nieuwenhuis HK, De Groot PG. Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIbeta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation. Blood. 2003; 101:1864-1870.